The development of systemic lupus erythematosus (SLE) after 38 months of therapy with recombinant human interferon gamma (rIFN-gamma) was observed in a patient with rheumatoid arthritis.
SLE
recombinant human interferon gamma
systemic lupus erythematosus
rIFN-gamma
systemic lupus erythematosus
recombinant human interferon gamma
SLE
rIFN-gamma